Delfi Diagnostics Enters into Research Agreement with Cancer Center
Delfi Diagnostics has entered into a broad research agreement with Memorial Sloan Kettering Cancer Center’s Biomarker Development Program.
Read More
Search Results for: lung cancer
Datar Announces $250M Contract for Cancer Detection Liquid Biopsies
Datar announced a contract with Artemis DNA, which provides Next Generation Sequencing genetic testing and diagnostic laboratory services.
Read More
Gene Deletion Behind Anomaly in Blood Cancer Cells
Research has provided more clues on the origins and progression of certain blood cancers, suggesting new ways to diagnose and treat leukemias.
Read More
Researchers Develop Model to Detect & Combat Lung Cancer Recurrence
Researchers found a process to study the actions of circulating tumor cells responsible for cancer recurrence of non-small cell lung cancer.
Read More
FDA Approves FoundationOne CDx as Companion Diagnostic for EGFR Therapeutics
Foundation Medicine’s tissue-based test is a genomic profiling test approved as a companion diagnostic for a group of targeted therapies.
Read More